Author: Calder, Philip C.
Title: n−3 Fatty acids, inflammation, and immunity— Relevance to postsurgical and critically III patients Cord-id: al94gxjw Document date: 2004_1_1
ID: al94gxjw
Snippet: Excessive or inappropriate inflammation and immunosuppression are components of the response to surgery, trauma, injury, and infection in some individuals and these can lead, progressively, to sepsis and septic shock. The hyperinflammation is characterized by the production of inflammatory cytokines, arachidonic acid-derived eicosanoids, and other inflammatory mediators, while the immunosuppression is characterized by impairment of antigen presentation and of T helper cell type-1 responses. Long
Document: Excessive or inappropriate inflammation and immunosuppression are components of the response to surgery, trauma, injury, and infection in some individuals and these can lead, progressively, to sepsis and septic shock. The hyperinflammation is characterized by the production of inflammatory cytokines, arachidonic acid-derived eicosanoids, and other inflammatory mediators, while the immunosuppression is characterized by impairment of antigen presentation and of T helper cell type-1 responses. Long-chain n−3 FA from fish oil decrease the production of inflammatory cytokines and eicosanoids. They act both directly (by replacing arachidonic acid as an eicosanoid substrate and by inhibiting arachidonic acid metabolism) and indirectly (by altering the expression of inflammatory genes through effects on transcription factor activation). Thus, long-chain n−3 FA are potentially useful anti-inflammatory agents and may be of benefit in patients at risk of developing sepsis. As such, an emerging application of n−3 FA is in surgical or critically ill patients where they may be added to parenteral or enteral formulas. Parenteral or enteral nutrition including n−3 FA appears to preserve immune function better than standard formulas and appears to partly prevent some aspects of the inflammatory response. Studies to date are suggestive of clinical benefits from these approaches, especially in postsurgical patients.
Search related documents:
Co phrase search for related documents- acute respiratory distress syndrome and long chain: 1, 2
- acute respiratory distress syndrome and low amount: 1
- acute respiratory distress syndrome and low concentration: 1
- acute respiratory distress syndrome and lox lipoxygenase: 1
- acute respiratory distress syndrome and lung edema: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
- acute respiratory distress syndrome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute respiratory distress syndrome and lung function heart: 1, 2, 3, 4, 5, 6
- acute respiratory distress syndrome and lymph node: 1, 2
- acute respiratory distress syndrome and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory distress syndrome and macrophage production: 1, 2
- adhesion molecule and lox lipoxygenase: 1
- adhesion molecule and lox lipoxygenase cox cyclooxygenase: 1
- adhesion molecule and lung edema: 1, 2, 3
- adhesion molecule and lung function: 1, 2, 3
- adhesion molecule and lung function heart: 1
- adhesion molecule and lymph node: 1, 2, 3, 4
- adhesion molecule and macrophage monocyte: 1
- adhesion molecule and macrophage production: 1
- long chain and low concentration: 1
Co phrase search for related documents, hyperlinks ordered by date